Published in Chem Res Toxicol on November 04, 1991
Solution structure of a highly stable DNA duplex conjugated to a minor groove binder. Nucleic Acids Res (1998) 1.03
Stereochemistry-dependent bending in oligonucleotide duplexes induced by site-specific covalent benzo[a]pyrene diol epoxide-guanine lesions. Nucleic Acids Res (1995) 0.90
(+)-CC-1065 as a structural probe of Mu transposase-induced bending of DNA: overcoming limitations of hydroxyl-radical footprinting. Nucleic Acids Res (1993) 0.85
Rapid and efficient hybridization-triggered crosslinking within a DNA duplex by an oligodeoxyribonucleotide bearing a conjugated cyclopropapyrroloindole. Nucleic Acids Res (1996) 0.82
Inhibition of human telomerase by a G-quadruplex-interactive compound. J Med Chem (1997) 2.66
G-quadruplex DNA: a potential target for anti-cancer drug design. Trends Pharmacol Sci (2000) 1.94
Selective interactions of cationic porphyrins with G-quadruplex structures. J Am Chem Soc (2001) 1.91
A DNA polymerase stop assay for G-quadruplex-interactive compounds. Nucleic Acids Res (1999) 1.68
Effects of cationic porphyrins as G-quadruplex interactive agents in human tumor cells. Cancer Res (1999) 1.63
Induction of duplex to G-quadruplex transition in the c-myc promoter region by a small molecule. J Biol Chem (2000) 1.54
Ecteinascidin 743: a minor groove alkylator that bends DNA toward the major groove. J Med Chem (1999) 1.48
NMR-Based model of a telomerase-inhibiting compound bound to G-quadruplex DNA. Biochemistry (1998) 1.45
Reaction of the antitumor antibiotic CC-1065 with DNA: structure of a DNA adduct with DNA sequence specificity. Science (1984) 1.44
Effect of DNA secondary structure on human telomerase activity. Biochemistry (1998) 1.43
Reaction of the antitumor antibiotic CC-1065 with DNA. Location of the site of thermally induced strand breakage and analysis of DNA sequence specificity. Biochemistry (1985) 1.37
Accelerated assembly of G-quadruplex structures by a small molecule. Biochemistry (1999) 1.36
Quadruplex-interactive agents as telomerase inhibitors: synthesis of porphyrins and structure-activity relationship for the inhibition of telomerase. J Med Chem (2001) 1.28
Sequence selectivity of DNA covalent modification. Chem Res Toxicol (1992) 1.28
Disorder trapping during crystallization of the B2-ordered NiAl compound. Phys Rev E Stat Nonlin Soft Matter Phys (2012) 1.23
DNA sequence specificity of the pyrrolo[1,4]benzodiazepine antitumor antibiotics. Methidiumpropyl-EDTA-iron(II) footprinting analysis of DNA binding sites for anthramycin and related drugs. Biochemistry (1986) 1.12
Mechanism of interaction of CC-1065 (NSC 298223) with DNA. Cancer Res (1982) 1.11
Telomere-interactive agents affect proliferation rates and induce chromosomal destabilization in sea urchin embryos. Anticancer Drug Des (1999) 1.11
Pyrrolo(1,4)benzodiazepine antitumor antibiotics. Comparative aspects of anthramycin, tomaymycin and sibiromycin. J Antibiot (Tokyo) (1977) 1.10
Pyrrol[1,4]benzodiazepine antibiotics. Proposed structures and characteristics of the in vitro deoxyribonucleic acid adducts of anthramycin, tomaymycin, sibiromycin, and neothramycins A and B. Biochemistry (1981) 1.07
Structure of the altromycin B (N7-guanine)-DNA adduct. A proposed prototypic DNA adduct structure for the pluramycin antitumor antibiotics. Biochemistry (1993) 1.07
The chemistry, mechanism of action and biological properties of CC-1065, a potent antitumor antibiotic. J Antibiot (Tokyo) (1986) 1.02
Thermally induced DNA.RNA hybrid to G-quadruplex transitions: possible implications for telomere synthesis by telomerase. Biochemistry (1996) 1.00
Regulation of catalytic activity and processivity of human telomerase. Biochemistry (1999) 1.00
Design and synthesis of fluoroquinophenoxazines that interact with human telomeric G-quadruplexes and their biological effects. Mol Cancer Ther (2001) 1.00
Pyrrolo[1,4]benzodiazepine antibiotics. Biosynthesis of the antitumor antibiotic 11-demethyltomaymycin and its biologically inactive metabolite oxotomaymycin by Streptomyces achromogenes. Biochemistry (1976) 0.99
Proposed structure of the anthramycin-DNA adduct. Nature (1979) 0.99
Telomerase assay using biotinylated-primer extension and magnetic separation of the products. Biotechniques (1998) 0.98
Structure of the (+)-CC-1065-DNA adduct: critical role of ordered water molecules and implications for involvement of phosphate catalysis in the covalent reaction. Biochemistry (1991) 0.97
TBP binding to the TATA box induces a specific downstream unwinding site that is targeted by pluramycin. Chem Biol (1995) 0.96
Inhibition of unwinding of G-quadruplex structures by Sgs1 helicase in the presence of N,N'-bis[2-(1-piperidino)ethyl]-3,4,9,10-perylenetetracarboxylic diimide, a G-quadruplex-interactive ligand. Biochemistry (2000) 0.95
Self-assembly of a quinobenzoxazine-Mg2+ complex on DNA: a new paradigm for the structure of a drug-DNA complex and implications for the structure of the quinolone bacterial gyrase-DNA complex. J Med Chem (1995) 0.95
Biosynthesis of anthramycin. Determination of the labeling pattern by the use of radioactive and stable isotope techniques. J Am Chem Soc (1975) 0.93
Molecular struggle for transcriptional control. Nat Med (1995) 0.93
Telomere maintenance mechanisms as a target for drug development. Oncogene (2000) 0.92
The antitumor agent CC-1065 inhibits helicase-catalyzed unwinding of duplex DNA. Biochemistry (1992) 0.92
Structure of a covalent DNA minor groove adduct with a pyrrolobenzodiazepine dimer: evidence for sequence-specific interstrand cross-linking. J Med Chem (1994) 0.90
Pyrrolo[1,4]benzodiazepine antitumor antibiotics: evidence for two forms of tomaymycin bound to DNA. Biochemistry (1986) 0.90
Pyrrolo(1,4)benzodiazepine antitumor antibiotics. In vitro interaction of anthramycin, sibiromycin and tomaymycin with DNA using specifically radiolabelled molecules. Biochim Biophys Acta (1977) 0.90
Binding of the maize cytosolic Hsp70 to calmodulin, and identification of calmodulin-binding site in Hsp70. Plant Cell Physiol (2000) 0.89
Does aluminum inhibit pollen germination via extracellular calmodulin? Plant Cell Physiol (2000) 0.89
Structural insight into a quinolone-topoisomerase II-DNA complex. Further evidence for a 2:2 quinobenzoxazine-mg2+ self-assembly model formed in the presence of topoisomerase ii. J Biol Chem (1999) 0.88
Cationic porphyrins promote the formation of i-motif DNA and bind peripherally by a nonintercalative mechanism. Biochemistry (2000) 0.88
Demonstration of a C-methylating enzyme in cell free extracts of indolmycin-producing Streptomyces griseus. Biochem Biophys Res Commun (1970) 0.87
Topoisomerase II-mediated site-directed alkylation of DNA by psorospermin and its use in mapping other topoisomerase II poison binding sites. Proc Natl Acad Sci U S A (1998) 0.87
Differential rates of reversibility of ecteinascidin 743-DNA covalent adducts from different sequences lead to migration to favored bonding sites. J Am Chem Soc (2001) 0.86
Characterization of a 12-mer duplex d(GGCGGAGTTAGG).d(CCTAACTCCGCC) containing a highly reactive (+)-CC-1065 sequence by 1H and 31P NMR, hydroxyl-radical footprinting, and NOESY restrained molecular dynamics calculations. Chem Res Toxicol (1992) 0.85
Protection against anthramycin-induced toxicity in mice by coenzyme Q10. J Natl Cancer Inst (1980) 0.85
(+)-CC-1065 as a structural probe of Mu transposase-induced bending of DNA: overcoming limitations of hydroxyl-radical footprinting. Nucleic Acids Res (1993) 0.85
Cooperative bending of the 21-base-pair repeats of the SV40 viral early promoter by human Sp1. Biochemistry (1994) 0.85
Reaction of anthramycin with DNA. Biological consequences of DNA damage in normal and xeroderma pigmentosum cell. J Biol Chem (1982) 0.84
Pyrrolo (1,4) benzodiazepine antitumor antibiotics: Biosynthetic studies on the conversion of tryptophan to the anthranilic acid moieties of sibiromycin and tomaymycin. Antimicrob Agents Chemother (1979) 0.84
Biosynthesis of indoleisopropionic acid by Claviceps. Biological C-methylation involving an intact methyl group. Arch Biochem Biophys (1969) 0.84
Topoisomerase II site-directed alkylation of DNA by psorospermin and its effect on topoisomerase II-mediated DNA cleavage. J Biol Chem (1998) 0.84
The biosynthesis of indolmycin. J Am Chem Soc (1971) 0.83
Structural distortions induced by integration host factor (IHF) at the H' site of phage lambda probed by (+)-CC-1065, pluramycin, and KMnO4 and by DNA cyclization studies. Biochemistry (1996) 0.83
A-tract and (+)-CC-1065-induced bending of DNA. Comparison of structural features using non-denaturing gel analysis, hydroxyl-radical footprinting, and high-field NMR. Biochemistry (1993) 0.82
Characterization of a unique tomaymycin-d(CICGAATTCICG)2 adduct containing two drug molecules per duplex by NMR, fluorescence, and molecular modeling studies. Biochemistry (1990) 0.82
Effect of the (+)-CC-1065-(N3-adenine)DNA adduct on in vitro DNA synthesis mediated by Escherichia coli DNA polymerase. Biochemistry (1992) 0.82
Depletion of nicotinamide adenine dinucleotide in normal and xeroderma pigmentosum fibroblast cells by the antitumor drug CC-1065. Biochemistry (1986) 0.82
Demonstration of the asymmetric effect of CC-1065 on local DNA structure using a site-directed adduct in a 117-base-pair fragment from M13mp1. Proc Natl Acad Sci U S A (1987) 0.82
DNA as a target for drug action. Trends Pharmacol Sci (1988) 0.82
Determination of the structural features of (+)-CC-1065 that are responsible for bending and winding of DNA. Chem Res Toxicol (1992) 0.82
Integrin-like proteins in the pollen tube: detection, localization and function. Plant Cell Physiol (2000) 0.82
A model for the T-antigen-induced structural alteration of the SV40 replication origin based upon experiments with specific probes for bent, straight, and unwound DNA. Biochemistry (1996) 0.82
Targeting telomeres and telomerase. Methods Enzymol (2001) 0.81
Pyrrolo[1,4]benzodiazepine antibiotics. Biosynthetic conversion of tyrosine to the C2- and C3-proline moieties of anthramycin, tomaymycin, and sibiromycin. Biochemistry (1979) 0.81
Regulation of antibiotic production: catabolite inhibition and the dualistic effect of glucose on indolmycin production. J Antibiot (Tokyo) (1974) 0.81
Inhibition of T4 DNA ligase activity by (+)-CC-1065: demonstration of the importance of the stiffening and winding effects of (+)-CC-1065 on DNA. Anticancer Drug Des (1992) 0.81
Pyrrolo[1,4]benzodiazepine antibiotics. Biosynthesis of the antitumor antibiotic sibiromycin by Streptosporangium sibiricum. Biochemistry (1979) 0.80
Recognition and repair of the CC-1065-(N3-adenine)-DNA adduct by the UVRABC nucleases. Biochemistry (1988) 0.80
Synthesis and biochemical evaluation of the CBI-PDE-I-dimer, a benzannelated analog of (+)-CC-1065 that also produces delayed toxicity in mice. J Med Chem (1993) 0.80
Characterization of an adduct between CC-1065 and a defined oligodeoxynucleotide duplex. Nucleic Acids Res (1984) 0.80
Correlation of DNA sequence specificity of anthramycin and tomaymycin with reaction kinetics and bending of DNA. Biochemistry (1993) 0.80
Accurate determination of quadruplex binding affinity and potency of G-quadruplex-interactive telomerase inhibitors by use of a telomerase extension assay requires varying the primer concentration. Anticancer Drug Des (1999) 0.80
Molecular approaches to achieving control of gene expression by drug intervention at the transcriptional level. Anticancer Drug Des (1999) 0.80
Construction and characterization of a site-directed CC-1065-N3-adenine adduct within a 117 base pair DNA restriction fragment. Biochemistry (1986) 0.80
Binding of Sp1 to the 21-bp repeat region of SV40 DNA: effect of intrinsic and drug-induced DNA bending between GC boxes. Gene (1994) 0.79
Isolation and absolute configuration of indolmycenic acid, an intermediate in the biosynthesis of indolmycin by Streptomyces griseus. Tetrahedron Lett (1970) 0.79
Alkylation of guanine and cytosine in DNA by bizelesin. Evidence for a covalent immobilization leading to a proximity-driven alkylation of normally unreactive bases by a (+)-CC-1065 cross-linking compound. Chem Res Toxicol (1994) 0.78
Determination of the major tautomeric form of the covalently modified adenine in the (+)-CC-1065-DNA adduct by 1H and 15N NMR studies. Biochemistry (1990) 0.78
Template-directed design of a DNA-DNA cross-linker based upon a bis-tomaymycin-duplex adduct. J Med Chem (1992) 0.78
In vitro and in vivo stability of anthramycin-DNA conjugate and its potential application as an anthramycin prodrug. Cancer Res (1979) 0.78
Biosynthesis of the antitumor antibiotic CC-1065 by Streptomyces zelensis. J Antibiot (Tokyo) (1983) 0.78
Repair of helix-stabilizing anthramycin-N2 guanine DNA adducts by UVRA and UVRB proteins. J Mol Biol (1991) 0.77
DNA interstrand cross-linking, DNA sequence specificity, and induced conformational changes produced by a dimeric analog of (+)-CC-1065. Anticancer Drug Des (1991) 0.77
Design of new topoisomerase II inhibitors based upon a quinobenzoxazine self-assembly model. J Med Chem (1998) 0.77
Neuronal RNA in nucleus ambiguus and nucleus hypoglossus of patients with amyotrophic lateral sclerosis. J Neuropathol Exp Neurol (1989) 0.77
Structure-activity relationships of (+)-CC-1065 analogues in the inhibition of helicase-catalyzed unwinding of duplex DNA. J Med Chem (1992) 0.77
[Efficacy of ablendazole emulsion in treatment of 212 patients with cystic echinococcosis]. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi (2001) 0.77
[Influences of intranigral injection of kainic acid on electroacupuncture analgesia and morphine analgesia in the rabbits]. Zhen Ci Yan Jiu (1986) 0.77
The reaction of anthramycin with DNA. Proton and carbon nuclear magnetic resonance studies on the structure of the anthramycin-DNA adduct. J Biol Chem (1984) 0.77
Regional mRNA changes in brain stem motor neurons from patients with amyotrophic lateral sclerosis. Mol Chem Neuropathol (1992) 0.76
Chemical conversion of anthramycin 11-methyl ether to didehydroanhydroanthramycin and its utilization in studies of the biosynthesis and mechanism of action of anthramycin. J Nat Prod (1981) 0.76
Design and synthesis of a novel DNA-DNA interstrand adenine-guanine cross-linking agent. J Am Chem Soc (2001) 0.76
Coenzyme Q10 or alpha-tocopherol reduce the acute toxicity of anthramycin in mice. Res Commun Chem Pathol Pharmacol (1979) 0.76
The quinobenzoxazines: relationship between DNA binding and biological activity. Anticancer Drug Des (1999) 0.75